Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Prediction of Time-to-First Treatment (TTFT) in Favorable-Risk Chronic Lymphocytic Leukemia (CLL) Patients Using a Novel Stratification through Transcriptome Risk Scoring

Boyu Hu, Brian Avery, Rosalie Griffin, Julie Feusier, Ahmad Halwani, Justin Williams, Brandt Jones, Michael Madsen, Deborah M. Stephens, Nicola J Camp

Blood (2023) 142 (Supplement 1): 1913.

https://doi.org/10.1182/blood-2023-178248

Published: 2023

Journal Articles

CD229 CAR T Cell Therapy for the Treatment of Relapsed B Cell Lymphoma

Michael Olson, Tim Luetkens, Fiorella Iglesias, Sabarinath Radhakrishnan, Jennie Y. Law, Stephanie Avila, Erica Vander Mause, Nicola J Camp, Erin Morales, Aaron P. Rapoport, Saurabh Dahiya, Joshua Brody, Alana Welm, Djordje Atanackovic

Blood (2021) 138 (Supplement 1): 2800.

https://doi.org/10.1182/blood-2021-154503

Published: 2021

Journal Articles

Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families

Blood (2021) 137 (15): 2046–2056.

https://doi.org/10.1182/blood.2020006322

Published: 2021

Includes: Supplemental data

Journal Articles

Association between a Polygenic Risk Score for Multiple Myeloma Risk and Overall Survival

Blood (2019) 134 (Supplement_1): 4366.

https://doi.org/10.1182/blood-2019-126088

Published: 2019

Journal Articles

Large-Scale Linkage Analysis of Multiple Myeloma (MM) and Monoclonal Gammopathy of Undetermined Significance (MGUS) Families

Alyssa I. Clay-Gilmour, BS, PhD, Nicola J Camp, PhD, Xiaomu Wei, PhD, Aaron D. Norman, Jason P Sinnwell, MS, Delphine Demangel, Rosalie Griffin Waller, BS, Charles Dumontet, James McKay, Kenneth Offit, MD, Siwei Chen, Daniel R O'Brien, S. Vincent Rajkumar, MD, Robert Klein, PhD, Shaji K. Kumar, MD, Steven Lipkin, MD PhD, Susan L. Slager, PhD, Celine M. Vachon, PhD

Blood (2018) 132 (Supplement 1): 4501.

https://doi.org/10.1182/blood-2018-99-119320

Published: 2018

Journal Articles

Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

Blood (2018) 131 (23): 2541–2551.

https://doi.org/10.1182/blood-2017-11-814608

Published: 2018

Includes: Supplemental data

Journal Articles

Common Genetic Polymorphisms Contribute to the Association between Non-Melanoma Skin Cancer and Chronic Lymphocytic Leukemia

Caroline Besson, MDPhD, Amy Moore, Wenting Wu, Nicola J Camp, PhD, Claire Vajdic, Lindsay M. Morton, PhD, Karin E Smedby, MD PhD, Silvia de Sanjose, Tait D Shanafelt, MD, Jerry Brewer, Lydia Zablotska, Eric A. Engels, MD MPH, James R. Cerhan, MD PhD, Susan L Slager, PhD, Jiali Han, Sonja I Berndt, PhD

Blood (2017) 130 (Supplement 1): 1454.

https://doi.org/10.1182/blood.V130.Suppl_1.1454.1454

Published: 2017

Journal Articles

A Genome-Wide Association Study of Myeloma Survival in Utah Uncovers Germline Variants That May Influence Survival of Multiple Myeloma Patients

Karen Curtin, PhD, Yi Zhao, MS, Donglei Hu, PhD, Guido J Tricot, MD PhD, Elad Ziv, MD, Djordje Atanackovic, MD, Nicola J Camp, PhD

Blood (2015) 126 (23): 2993.

https://doi.org/10.1182/blood.V126.23.2993.2993

Published: 2015

Journal Articles

Elevated Rates of Monoclonal Gammopathy in High-Risk Chronic Lymphocytic Leukemia Pedigrees

Nicola J Camp, PhD, Rosalie G Waller, BS, Cassandra Garner, BS, Guido J Tricot, MD PhD, Michael Tomasson, MD, Djordje Atanackovic, MD, Martha Glenn, MD

Blood (2015) 126 (23): 1449.

https://doi.org/10.1182/blood.V126.23.1449.1449

Published: 2015

Journal Articles

Exome Sequencing in Myeloma Pedigrees Implicates RAS1 and NOTCH Signaling Are Involved in Inherited Myeloma Risk

Rosalie G Waller, BS, Karen Curtin, PhD, Djordje Atanackovic, MD, Guido J Tricot, MD PhD, Steven M Lipkin, MD PhD, Nicola J Camp, PhD

Blood (2015) 126 (23): 2976.

https://doi.org/10.1182/blood.V126.23.2976.2976

Published: 2015

Journal Articles

Disruption of the SUMO Pathway in a High-Risk B-Cell Non-Hodgkin Lymphoma Pedigree

Cassandra Garner, BS, Martha Glenn, MD, Rosalie G Waller, BS, Venkatesh Rajamanickam, MS, Todd Darlington, PhD, Rob Sargent, MS, Nicola J Camp, PhD

Blood (2015) 126 (23): 2682.

https://doi.org/10.1182/blood.V126.23.2682.2682

Published: 2015

Journal Articles

Inherited Giant Platelet Disorder, Kashmiri Thrombocytopenia, a Common Syndrome Found in Srinagar, India

Felipe R Lorenzo, PhD, Tsewang Tashi, MD, Parvaiz Koul, MD, Nicola J Camp, PhD, Perumal Thiagarajan, MD, Josef T. Prchal, MD

Blood (2014) 124 (21): 4211.

https://doi.org/10.1182/blood.V124.21.4211.4211

Published: 2014

Journal Articles

Exome Sequencing in a Family with Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma and Autoimmune Disease Uncovers Potential Germline Risk-Alleles

Martha J Glenn, MD, Rosalie G Waller, Nicola J Camp, PhD

Blood (2014) 124 (21): 5629.

https://doi.org/10.1182/blood.V124.21.5629.5629

Published: 2014

Journal Articles

Genetic evidence of PTPN22 effects on chronic lymphocytic leukemia

Scott J. Hebbring, Susan L. Slager, Narendranath Epperla, Joseph J. Mazza, Zhan Ye, Zhiyi Zhou, Sara J. Achenbach, Daniel A. Vasco, Timothy G. Call, Kari G. Rabe, Neil E. Kay, Neil E. Caporaso, Mark C. Lanasa, Nicola J. Camp, Sara S. Strom, Lynn R. Goldin, James R. Cerhan, Murray H. Brilliant, Steven J. Schrodi

Blood (2013) 121 (1): 237–238.

https://doi.org/10.1182/blood-2012-08-450221

Published: 2013

Journal Articles

Common variation at 6p21.31 ( BAK1 ) influences the risk of chronic lymphocytic leukemia

Blood (2012) 120 (4): 843–846.

https://doi.org/10.1182/blood-2012-03-413591

Published: 2012

Includes: Supplemental data

Journal Articles

Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL

Blood (2011) 117 (6): 1911–1916.

https://doi.org/10.1182/blood-2010-09-308205

Published: 2011

Includes: Supplemental data

Journal Articles

Monoclonal B-Cell Lymphocytosis Is Commonly Observed Among Unaffected Members of High Risk CLL Families.

Blood (2009) 114 (22): 1232.

https://doi.org/10.1182/blood.V114.22.1232.1232

Published: 2009

Journal Articles

Family-Associated Monoclonal B Lymphocytosis Shows Differences From CLL That Suggest An Indolent Biology.

Mark C Lanasa, MD, PhD, Sallie D Allgood, MS, Susan L Slager, PhD, Nicola J Camp, PhD, Neil E. Kay, MD, Logan G Spector, PhD, Laura Z. Rassenti, PhD, Curtis A. Hanson, MD, Jon P Gockerman, MD, Barbara K Goodman, PhD, Sara S Strom, PhD, Timothy G Call, MD, James R Cerhan, MD, PhD, Jose Leis, MD, Gerald Marti, MD, PhD, Lynn Goldin, PhD, J. Brice Weinberg, Neil E Caporaso, MD

Blood (2009) 114 (22): 1241.

https://doi.org/10.1182/blood.V114.22.1241.1241

Published: 2009

NARROW

Prediction of Time-to-First Treatment (TTFT) in Favorable-Risk Chronic Lymphocytic Leukemia (CLL) Patients Using a Novel Stratification through Transcriptome Risk Scoring

CD229 CAR T Cell Therapy for the Treatment of Relapsed B Cell Lymphoma

Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families

Association between a Polygenic Risk Score for Multiple Myeloma Risk and Overall Survival

Large-Scale Linkage Analysis of Multiple Myeloma (MM) and Monoclonal Gammopathy of Undetermined Significance (MGUS) Families

Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

Common Genetic Polymorphisms Contribute to the Association between Non-Melanoma Skin Cancer and Chronic Lymphocytic Leukemia

A Genome-Wide Association Study of Myeloma Survival in Utah Uncovers Germline Variants That May Influence Survival of Multiple Myeloma Patients

Elevated Rates of Monoclonal Gammopathy in High-Risk Chronic Lymphocytic Leukemia Pedigrees

Exome Sequencing in Myeloma Pedigrees Implicates RAS1 and NOTCH Signaling Are Involved in Inherited Myeloma Risk

Disruption of the SUMO Pathway in a High-Risk B-Cell Non-Hodgkin Lymphoma Pedigree

Inherited Giant Platelet Disorder, Kashmiri Thrombocytopenia, a Common Syndrome Found in Srinagar, India

Exome Sequencing in a Family with Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma and Autoimmune Disease Uncovers Potential Germline Risk-Alleles

Genetic evidence of PTPN22 effects on chronic lymphocytic leukemia

Common variation at 6p21.31 ( BAK1 ) influences the risk of chronic lymphocytic leukemia

Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL

Monoclonal B-Cell Lymphocytosis Is Commonly Observed Among Unaffected Members of High Risk CLL Families.

Family-Associated Monoclonal B Lymphocytosis Shows Differences From CLL That Suggest An Indolent Biology.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only